Wave Life Sciences Ltd.
WVENASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $648.75M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.04$21.73
- Volume (live)
- -
- Avg. volume (3M)
- 3.10M
Wave Life Sciences (WVE) Stock Price & Financial Analysis
Wave Life Sciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.12 - $3.34 |
|---|---|
| 52-Week High | $21.73 |
| 52-Week Low | $3.04 |
| Open | $3.33 |
| Volume (last close) | 2.66M |
| Average Volume (3M) | 3.10M |
| Revenue (TTM) | 65.37M |
|---|---|
| Net Income (TTM) | -202.47M |
| Free Cash Flow (TTM) | -191.48M |
| EPS (TTM) | −$1.08 |
| Profit Margin | -309.73% |
| Operating Margin | -333.36% |
| Return on Equity (ROE) | -44.64% |
| Debt to Equity | 0.10 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 648.75M |
|---|---|
| Shares Outstanding | 204.01M |
| Price to Sales (P/S) | 9.92 |
| Price to Book (P/B) | 1.43 |
| EV/EBITDA | -1.76 |
| 50-Day MA | $4.36 |
|---|---|
| 200-Day MA | $7.87 |
| 1-Year Change | −52.48% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Wave Life Sciences at a Glance
As of the Oct 23, 2026 close, Wave Life Sciences (WVE) has a market capitalization of $648.75M. The stock trades at 9.9× sales. Over the trailing twelve months it lost $202.47M on revenue of $65.37M and burned $191.48M of free cash flow. Revenue fell 30.4% year over year.
As of its latest reported balance sheet, it holds $368.01M in cash and securities against $43.59M of debt, a net cash position of $324.42M.
Wave Life Sciences does not currently pay a dividend.
The share price is down 52.5% over the past year. At $3.18 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $3.04 to $21.73, below its 200-day moving average of $7.87.
Based on 16 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $18.74, 489.3% above the Oct 23, 2026 close.
Frequently Asked Questions About Wave Life Sciences
What is the current stock price for WVE?
As of the Oct 23, 2026 close, WVE stock trades at $3.18. The 52-week range is $3.04–$21.73, with a day range of $3.12–$3.34.
What is the P/E ratio for WVE?
The P/E ratio (Price-to-Earnings) for WVE is shown in the Key Statistics section. This valuation metric helps compare Wave Life Sciences Ltd. to industry peers.
Does WVE pay dividends?
Wave Life Sciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for WVE?
Based on ratings from 16 professional analysts over the last 90 days, the consensus for WVE is Buy. The average 12-month price target is $18.74, a 489.3% upside from the Oct 23, 2026 close of $3.18.
What is the market cap of WVE?
As of the Oct 23, 2026 close, Wave Life Sciences's market capitalization is $648.7M, classifying it as a small-cap company. Wave Life Sciences operates in the Healthcare sector within the Biotechnology industry.